ASPREE Completion Project [ 2017 - 2018 ]

Research Grant

Researchers: Prof John Mcneil (Principal investigator) ,  A/Pr Robyn Woods ,  Prof Andrew Tonkin ,  Prof Mark Nelson

Brief description ASPREE is the largest clinical trial ever conducted in Australia and will determine whether daily low dose aspirin prevents disease in healthy older people. The study was well-funded initially but will require additional support to complete the vital final stage of data collection and analysis. This will enable the study to answer important questions about the benefits and risks of aspirin in this age group and its effect on disability free survival.

Funding Amount $AUD 4,877,579.35

Funding Scheme Project Grants

Notes Standard Project Grant